Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary
Background: As biosimilars have become available in various parts of the world, the International Psoriasis Council has reviewed aspects of their use. Objective: To provide consensus statements from the Biosimilar Working Group about the use of biosimilars in patients with psoriasis. Methods: A semi...
Main Authors: | Arnon D. Cohen, MD, MPH, PhD, Ronald Vender, MD, FRCPC, Luigi Naldi, MD, Robert E. Kalb, MD, Tiago Torres, MD, PhD, Murlidhar Rajagopalan, MD, Joelle van der Walt, PhD, Lluís Puig, MD (Hon), PhD, Helen S. Young, MB ChB, PhD, FRCP |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | JAAD International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328720300523 |
Similar Items
-
An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
by: Zhou X, et al.
Published: (2021-07-01) -
Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese Patients
by: Alexandra Azevedo, et al.
Published: (2018-09-01) -
Psoriasis vulgaris with fibrokeratoma from pityriasis amiantacea
by: Chihiro Shiiya, MD, et al.
Published: (2017-05-01) -
Late-onset development of psoriasis in Japan: a population-based cohort studyCapsule Summary
by: Haruka Goto, MD, et al.
Published: (2021-03-01) -
Granuloma annulare arising under systemic psoriasis therapy successfully treated with adalimumab
by: Mirjam Fässler, MD, et al.
Published: (2020-09-01)